Pre-referral rectal artesunate for severe malaria

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 5, 2014, Pages

  Okebe, Joseph ^a   Eisenhut, Michael ^b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; PLACEBO; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

AFRICA; BANGLADESH; COMA; CONVULSION; DISEASE SEVERITY; EARLY INTERVENTION; EMERGENCY CARE; HOSPITAL ADMISSION; HUMAN; MALARIA; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; PARASITEMIA; PATIENT REFERRAL; PATIENT TRANSPORT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADULT; AGE; CHILD; EMERGENCY HEALTH SERVICE; GHANA; HEALTH; INFANT; PRESCHOOL CHILD; PROCEDURES; RECTAL DRUG ADMINISTRATION; TANZANIA;

ADMINISTRATION, RECTAL; ADULT; AGE FACTORS; ANTIMALARIALS; ARTEMISININS; BANGLADESH; CHILD; CHILD, PRESCHOOL; EMERGENCY MEDICAL SERVICES; GHANA; HUMANS; INFANT; MALARIA; RURAL HEALTH; TANZANIA;

EID: 84907263641     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009964.pub2     Document Type: Review

References (35)

1. Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, et al.Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet 2009;373:557-66.
2. Aceng JR, Byarugaba JS, Tumwine JK. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. British Medical Journal (Clinical Research ed.) 2005;330(7487):334.
3. Early rectal artesunate is more effective at reducing parasite density compared with intramuscular quinine in people with moderately severe malaria. Evidence-Based Healthcare and Public Health. Vol. 8, 2004:375-6.
4. Barnes KI, Mwenechanya J, Tembo M, McIlleron H, Folb PI, Ribeiro I, et al.Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. Lancet 2004;363(9421):1598-605.
5. Gomes MF, Warsame M, Nasemba N, Singlovic J, Kapinga A, Mwankuyse S, et al.Gaining time: early treatment of severe pediatric malaria in Tanzania. Drug Development Research 2010;71(1):92-8.
6. Karunajeewa HA, Reeder J, Lorry K, Dabod E, Hamzah J, Page-Sharp M, et al.Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea. Antimicrobial Agents and Chemotherapy 2006;50(3):968-74.
7. Kitua A, Folb P, Warsame M, Binka F, Faiz A, Ribeiro I, et al.The use of placebo in a trial of rectal artesunate as initial treatment for severe malaria patients en route to referral clinics: ethical issues. Journal of Medical Ethics 2010;36(2):116-20.
8. Krishna S, Planche T, Agbenyega T, Woodrow C, Agranoff D, Bedu-Addo G, et al.Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrobial Agents and Chemotherapy 2001;45(2):509-16.
9. Awad MI, Alkadru AM, Behrens RH, Baraka OZ, Eltayeb IB. Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan. The American Journal of Tropical Medicine and Hygiene 2003;68(2):153-8.
10. Bello SO. Pre-referral artesunate in severe malaria. Lancet 2009;373:1762-3.
11. Dondorp A, Nosten F, Stepniewska K, Day N, White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005;366:717-25.
12. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, et al.Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010;376:1647-57.
13. German PI, Aweeka FT. Clinical pharmacology of artemisinin-based combination therapies. Clinical Pharmacokinetics 2008;47(2):91-102.
14. Gomes M, Ribeiro I, Warsame M, Karunajeewa H, Petzold M. Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies. BioMed Central Infectious Diseases 2008;8:39.
15. Gomes MF. Response to: Pre-referral rectal artesunate in severe malaria: a flawed trial. Trials 2011;12:189.
16. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
17. Hirji KF, Premji ZG. Pre-referral rectal artesunate in severe malaria: flawed trial. Trials 2011;12:188.
18. Inthavilay S, Franchard T, Meimei Y, Ashley EA, Barennes H. Knowledge and acceptability of the rectal treatment route in Laos and its application for pre-referral emergency malaria treatment. Malaria Journal 2010;9:342.
19. Kaatano GM, Mashauri FM, Kinung'hi SM, Mwanga JR, Malima RC, Kishamawe C, et al.Patterns of malaria related mortality based on verbal autopsy in Muleba District, north-western Tanzania. Tanzania Journal of Health Research 2009;11(4):210-8.
20. Kamugisha ML, Gesase S, Mlwilo TD, Mmbando BP, Segeja MD, Minja DT, et al.Malaria specific mortality in lowlands and highlands of Muheza district, north-eastern Tanzania. Tanzania Health Research Bulletin 2007;9(1):32-7.
21. Karunajeewa HA, Ilett KF, Dufall K, Kemiki A, Bockarie M, Alpers MP, et al.Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria. Antimicrobial Agents and Chemotherapy 2004;48(8):2966-72.
22. Karunajeewa HA, Manning L, Mueller I, Ilett KF, Davis TM. Rectal administration of artemisinin derivatives for the treatment of malaria. The Journal of the American Medical Association 2007;297(21):2381-90.
23. Lefebvre C, Manheimer E, Glanville J. Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. The Cochrane Collaboration, 2011.
24. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, et al.Indicators of life-threatening malaria in African children. New England Journal of Medicine 1995;332(21):1399-404.
25. Morris CA, Duparc S, Borghini-Fuhrer I, Jung D, Shin CS, Fleckenstein L. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malaria Journal 2011;10:263.
26. Mudenda SS, Kamocha S, Mswia R, Conkling M, Sikanyiti P, Potter D, et al.Feasibility of using a World Health Organization-standard methodology for Sample Vital Registration with Verbal Autopsy (SAVVY) to report leading causes of death in Zambia: results of a pilot in four provinces, 2010. Population Health Metrics 2011;9:40.
27. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
28. Sinclair D, Donegan S, Isba R, Lalloo DG. Artesunate versus quinine for treating severe malaria. The Cochrane Database of Systematic Reviews 2012;6:CD005967.
29. Stepniewska K, Taylor W, Sirima SB, Ouedraogo EB, Ouedraogo A, Gansane A, et al.Population pharmacokinetics of artesunate and amodiaquine in African children. Malaria Journal 2009;8:200.
30. Tozan Y, Klein EY, Darley S, Panicker R, Laxminarayan R, Breman JG. Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis. Lancet 2010;376(9756):1910-5.
31. World Health Organization. Severe and complicated malaria. Transactions of The Royal Society of Tropical Medicine and Hygiene 1990;84(Supplement 2):1-65.
32. World Health Organization. Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000;94(Suppl 1):S1-90.
33. World Health Organization. World Malaria Report. Geneva: World Health Organization, 2010.
34. World Health Organization. Guidelines for the treatment of malaria. 2nd Edition. Geneva: World Health Organization, 2010.
35. Wilairatana P, Viriyavejakul P, Looareesuwan S, Chongsuphajaisiddhi T. Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas. Annals of Tropical Medicine and Parasitology 1997;91(7):891-6.